Immunovaccine completes debt financing

Immunovaccine Inc. (TSX-V:IMV), Halifax, Nova Scotia Business: Cancer, Infectious Date completed: 8/2/13 Type: Debt financing Raised: $1.3 million Investor: Province of Nova Scotia Note: Immunovaccine...